Whole-body MRI for non-invasive lesion detection and therapy follow-up in radiographic and non-radiographic axial spondyloarthritis
Official title: Research on a New Disease Activity Assessment System for axSpA Based on Whole-body Magnetic Resonance Imaging Cohort
Run by The First Affiliated Hospital with Nanjing Medical University · NCT07230327 · Data updated 2026-11-12
This project will try whole-body MRI to find lesions and track treatment response in people with radiographic or non-radiographic axial spondyloarthritis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | The First Affiliated Hospital with Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | January 2026 |
| Study ends | December 2026 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT07230327 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Newly referred people with symptom onset before age 45 who have chronic back pain (>3 months) and/or peripheral arthritis, enthesitis, or dactylitis and who are not already diagnosed with axial SpA are the intended participants.
✕Probably not a fit
People already diagnosed with radiographic or non-radiographic axial SpA, those with symptom onset after age 45, or individuals with contraindications to MRI (for example certain implanted devices or severe claustrophobia) are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort using whole-body MRI (WB-MRI) to image multiple body regions in patients with suspected axial spondyloarthritis and to follow them over time. Imaging features from WB-MRI will be correlated with clinical measures of disease activity, inflammation, and structural damage. The project will apply data mining and machine-learning methods to build a WB-MRI–based disease activity model, with separate discovery and validation cohorts to test accuracy and reliability. Dynamic follow-up imaging will be used to examine how MRI findings change with therapy and clinical course.
Why it matters
Potential benefit: If successful, the project could provide a more objective, imaging-based way to measure disease activity and monitor treatment response in axial spondyloarthritis.
How similar studies have gone: Whole-body MRI has shown promise in small axSpA cohorts for detecting inflammation, but using WB-MRI combined with machine-learning to create a validated disease-activity model is relatively novel and not yet widely proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Include newly referred patients if: The onset of symptoms (back pain/arthritis/enthesitis) \< 45 years Undiagnosed disease with the following symptoms: chronic back pain (duration of back pain more than 3 months) and/or peripheral arthritis (asymmetric arthritis/predominantly of the lower limbs) and/or enthesitis and/or dactylitis Exclusion Criteria: And diagnosed with non-radiographic or radiographic axial SpA
Where it's running
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Wenfeng Tan, Dr
- Email: tw2006@njmu.edu.cn
- Phone: +8618061202878
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Validation of the 2025 Axial Spondyloarthritis Classification Criteria in Chinese patients
This study tests whether the 2025 ASAS-SPARTAN criteria correctly classify axial spondyloarthritis in adults with chronic back pain in China.
-
Observational cohort of patients with spondyloarthritis at Nanfang Hospital
This study is collecting health information from patients with spondyloarthritis at Nanfang Hospital to better understand the condition over time without changing their usual care.
-
Understanding pain in inflammatory joint diseases
This project will follow people with inflammatory joint diseases who are starting or switching biological or targeted synthetic DMARDs to try to identify different pain types and see if central sensitization and cognitive function relate to persistent pain.
-
Benzathine penicillin plus etanercept for spondyloarthritis
This trial will test whether adding benzathine penicillin to etanercept helps adults with spondyloarthritis reduce disease activity more than etanercept alone.
-
Registry for hereditary autoinflammatory diseases
This study is collecting information about hereditary autoinflammatory diseases to see how they affect patients of different ages and genders, with the goal of improving treatment and care for everyone affected.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.